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Abstract
Light-absorbing molecules can be used as powerful tools to perturb and understand biological
systems by fluorescence, sensitization, or photochemical reactions. A thorough understanding of the
delivery of dyes to specific biochemical targets and the processes that control the fate of excited-state
energy is needed to engineer useful technology out of organic photochemistry. This thesis presents four
projects investigating different aspects of pathogen destruction and biochemical sensing in a variety of
systems, using the properties of p-phenylene ethynylenes (PEs), an especially flexible and well-studied
class of conjugated molecules. Of particular relevance, some PEs are found to be effective dyes for
amyloid protein aggregates both in solution and in mouse and human brain tissue. As well, control of the
solvent microenvironment can be used to tune accessibility of the triplet state, which has implications for
targeted photodynamic inactivation of both pathogens and cancer cells.
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I. Introduction
Fluorescent dyes are an essential tool in modern biology for their ability to resolve
biological structures and processes in real time, and, in superresolved applications, with spatial
resolution close to that of individual molecular phenomena. Multiple layers of space/time
biological information can be collected from the same system by using multiple fluorescent
markers, and a well-characterized fluorophore can read out very detailed information about its
physical and chemical environment, making many dimensions of data available to the wellprepared biologist.1,2 To be capable of generating biologically relevant information, fluorophores
have to be meaningfully coupled to biological processes, whether by direct binding of ligandfluorophores to relevant structures, by conjugated antibody-antigen binding, or by genetic
methods such as the expression of intrinsically fluorescent proteins. Of these, the latter two have
more biological specificity, while the first is more direct, easiest to implement and has the least
variability.

Figure I.1. Jablonski energy level diagram (vibrational transitions omitted) detailing the
excitation and decay pathways relevant to the current discussion.
Non-emissive photoproperties of organic dyes have also found widespread applications in
many fields, including biomedical research and technology. Leaving aside the extensive history
of the process in film photography,3 the generation of reactive singlet oxygen as a result of
absorption of a quantum of light by a molecule has proven useful for destructive oxidation of
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unwanted cellular systems, including cancer cells and microbial and viral pathogens.
Photodynamic therapy exploits local dosing of a photosensitizer and local application of light
irradiation to selectively destroy cancer cells, and has many advantages over other cancer
therapies in cases where photoirradiation is convenient (i.e., cancers close to the surface of an
easily exposed tissue).4–6 The principles of cancer photodynamic therapy have been extended in
recent years to microbial pathogens, giving rise to the field of antimicrobial photodynamic
therapy.7
In the current thesis, we will examine four projects: synthesis of two minor variants of a
cationic oligo(phenylene ethynylene) bearing different cationic rings and brief testing against
bacteria; characterization of a subclass of solvent-sensitive OPEs as dyes for amyloid protein
aggregates; extension of the OPE amyloid dyes to staining of brain tissue sections; and a
spectroscopic exploration of triplet state populations in the solvent-sensitive dye class and their
controllability by self-assembly with surfactants.
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II. Synthesis of End-Functionalized OPEs
1. Background
Polymeric and oligomeric phenylene ethynylene electrolytes, especially those bearing
cations, have been demonstrated to inactivate bacteria, pathogenic fungi and viruses through both
light-dependent (photosensitization) and light-independent (membrane disruption) mechanisms,
while leaving mammalian cells relatively unharmed.8–11 Various configurations of cationic groups
and conjugated backbone have been investigated, leading to the development of overall design
principles. Cation-photosensitizers with a very short conjugated chain and cationic moieties at the
ends, rather than the side-chains, have been shown to be effective against viruses and bacterial
biofilms, and pathogenic fungal spores.12–14 These “end-only functionalized” conjugated
electrolytes’ lesser bulk is hypothesized to allow them to diffuse into and disrupt viral capsid
proteins and nucleic acids as well as the cellular components of biofilms. While these small
compounds are more easily leached and photobleached than larger polymeric or oligomeric
antimicrobials, their broad-spectrum inactivating ability against a variety of strategically
important pathogens is greater.
In the first project to be discussed in this thesis, existing methods for synthesis of endonly functionalized cationic OPEs (EO-OPEs) were extended by the preparation of imidazolium
and pyridinium derivatives of a triphenyl EO-OPE, named EO-IM and EO-PY. These derivatives
were prepared after the improved antimicrobial performance of an imidazolium-functionalized
poly(phenylene ethynylene) was demonstrated by Parthasarathy and Pappas.9
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Figure II.1. Synthetic scheme used to prepare EO-PY and EO-IM.

2. Methods
Synthesis of OPEs was accomplished mostly by literature methods, as summarized in
Figure II.1.15,16 Briefly, OPE precursors were prepared and coupled by Sonogashira reaction
catalyzed by (PPh3)2PdCl2 and CuI in a degassed mixture of dichloromethane and
diisopropylamine under Ar. The OPEs were prepared as a bromoalkyl ether, which was reacted
with 1-methyl imidazole (for EO-IM) or pyridine (for EO-PY) to form the final product.
Synthesis of 1-(3-bromopropoxy)-4-iodobenzene (2): K2CO3 (12.4 g, 10 eq) was added
to a stirring mixture of 40 mL acetonitrile with 5 mL of water in a round-bottomed flask in an oil
bath, followed by 4-iodophenol (2 g, 9 mmol). The flask was fitted with a reflux condenser, the
mixture heated to reflux and 1,3-dibromopropane (3.6 g, 1.8 mL, 2 eq) was added dropwise. After
12 hours at reflux, the excess base was removed by filtration and the reaction mixture washed
with 1N HCl, saturated NaHCO3, and saturated brine, and extracted with dichloromethane. The
organic fraction was removed, residual water removed by standing over MgSO4 for 30 minutes.
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Dichloromethane was removed by rotary evaporation and excess 1,3-dibromopropane by standing
in a watch glass overnight. Recovered 2.18 g of a white solid (71% yield).
Synthesis of 1,4-diethynylbenzene (5): 1,4-bis(trimethylsilyl)ethynylbenzene (1 g, 3.70
mmol) was added to a stirring solution of K2CO3 (5.1 g, 10 eq) in MeOH (40 mL). The solution
was stirred for 5 h at room temperature, the excess base removed by filtration, and the solvent
removed by rotary evaporation under reduced pressure. The residue was dissolved in
dichloromethane and washed sequentially with 1N HCl, saturated NaHCO3 and saturated brine.
Removal of solvent yielded 400 mg of 5 in 86% yield.
Synthesis of 1,4-bis((4-(3-bromopropoxy)phenyl)ethynyl)benzene (6): 5 (300 mg, 2.38
mmol) and 2 (1.95 g, 2.4 eq) were dissolved in 40 mL of a 1:1 mixture of dichloromethane and
diisopropylamine, and Pd(PPh3)2Cl2 (66.8 mg, 4 mol %) and CuI (36 mg, 8 mol %) were
suspended in 100 mL of a 1:1 mixture of dichloromethane and diisopropylamine which had been
sparged with Ar for 20 minutes. Both solutions were sealed with rubber septa and sparged with
Ar for 30 minutes, then cooled to 0oC. The reactants were added to the catalyst suspension by
cannula transfer under Ar pressure, and the reaction mixture was sealed with parafilm and fitted
with a balloon providing positive pressure of Ar. After 12 hours, 40 mL of dichloromethane was
added to the reaction mixture, the mixture was filtered and the solvent removed under reduced
pressure. The bright orange residue was resuspended in dichloromethane and washed sequentially
with saturated NH4Cl, saturated NaHCO3, and saturated brine. The organic layer was dried by
MgSO4, solvent removed under reduced pressure and the residue chromatographed on silica
using a 20:1 to 10:1 to 5:1 gradient of dichloromethane:methanol mixtures, yielding (197 mg,
15% yield).
Synthesis of EO-IM: 6 (50 mg, 0.09 mmol) was refluxed with 10 equivalents of 1methylimidazole overnight in acetonitrile. Solvent was removed under reduced pressure and the
liquid washed with water and dichloromethane, yielding 40 mg EO-PY in 80% yield.
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Synthesis of EO-PY: 6 (50 mg, 0.09 mmol) was refluxed with 10 equivalents of pyridine
overnight in acetonitrile. Both the solvent and excess pyridine were removed by long drying
under reduced pressure. 40 mg of EO-PY was produced in 80% yield.
Effectiveness of EO-IM and EO-PY against populations of S. aureus was evaluated by
live/dead stain flow cytometry. Bacterial cells were grown in nutrient broth, diluted to 1e6
cells/mL, and stock solutions of EO-IM, EO-PY and EO-DABCO added to a total concentration
of 5 ug/mL. The three OPE samples and a control were incubated for 30 minutes under 350 nm
UVA light in a photoreactor, stained with SYTO 9 and propidium iodide, and counted on a flow
cytometer (Accuri C6). The gates used to determine live and dead populations were derived from
previous control experiments using fresh incubated cells (live) and cells exposed to 70% EtOH
overnight (dead). These experiments were only performed at one set of concentrations, and were
not complete or conclusive.

3. Discussion & Conclusions

Figure II.2. ESI-MS exact mass spectrum of a sample containing EO-IM, indicating the presence
of an m/z peak at 278.1426 for a mass of 556.2852, 2.5 parts per million off from the expected
mass of 556.2838.

7

Figure II.3. ESI-MS exact mass spectrum of a sample containing EO-PY, indicating the presence
of an m/z peak at 275.1309 for a mass of 550.2618, 0.4 parts per million off from the expected
mass of 550.2620.

Figure II.4. Proton NMR spectrum of EO-PY with peak assignments and integration. The
“unidentified” impurity is water.

8

Figure II.6. Absorbance (left) and fluorescence spectra of EO-IM (those of EO-PY are identical).
Fluorescence is plotted on an arbitrary scale, absorbance in OD.
1

H NMR and mass spectrometry of EO-IM and EO-PY (Figures II.2-4) indicated that the

molecule was synthesized as intended and contained only trace impurities, with both molecular
weight and molecular connectivity determined as expected. Absorbance and fluorescence of EOIM is shown in Figure II.6, and is extremely similar to that of other EO-OPEs.

Figure II.7. Flow cytometric analysis of the S. aureus killing efficiency of EO-IM and EO-PY
under 30m UVA irradiation, compared to that of EO-OPE-DABCO. All OPEs were applied at a
concentration of 5 ug/mL.
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EO-IM and EO-PY were found to be equally as effective as EO-DABCO at killing of S.
aureus bacterial populations at the 5 ug/mL concentrations tested, with 99.8% of cells appearing
“dead” compared to 68.9% for UVA control. Characterization of these compounds is incomplete.
It is possible that the effectiveness of these compounds might vary significantly at different
concentrations, or against different organisms. These compounds were synthesized in an attempt
to explore the effect of different cationic groups on the antimicrobial effectiveness of different
OPEs. A full exploration of these effects was not completed and drawing any conclusions would
be premature. This work is included in this thesis in the hope that it might be continued in the
future, and yield some useful information about the effect of the cation group on the behavior of
these antimicrobial compounds.
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III. Using a Desolvation Trigger and Steric Targeting with
Amphiphilic Dyes: Sensing of Amyloids I
1. Background
The goal of this project is to develop new tools to improve the properties of biological
dyes, focusing on binding-activated changes in photophysical properties such as quantum yields
of fluorescence and photochemical sensitization. Amyloids are a class of beta-sheet-rich, linear
peptide intermolecular homopolymers found in healthy and diseased states in many living
systems.17 Amyloids form the major component of plaques found in neurodegenerative diseases
such as Alzheiemer’s, Parkinson’s, Huntington’s and others,18,19 the extracellular matrix secreted
by Enterobacteria,20 and deposits in the organs of some phenotypically healthy older people.21
The exceptional thermodynamic stability of amyloids, as well as their ability to template the
formation of further aggregates, forms the basis for transmission of prions, abiotic pathogens
responsible for various transmissible spongiform encephalopathies such as kuru, CreutzfeldtJakob disease and bovine spongiform encephalopathy (“mad cow disease”).22 The rich and varied
biochemistry of amyloids has been well-studied both due to their ostensible involvement in
certain diseases of enormous economic importance and their susceptibility to detection by the
binding of fluorescent dyes.
Regardless of the pathology, monitoring the course of amyloid formation at the
biochemical, cellular and tissue levels, both in humans and animal models, is vital to
understanding and combating AD and other proteinopathies23. Though conformation- and
sequence-specific antibodies have been developed for amyloid applications24, the primary means
of detecting and localizing amyloid aggregates are small-molecule probes, whether fluorescent
ligands, radiolabeled ligands for positron-emission tomography (PET)25 and single photon
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emission computed tomography (SPECT), or metal-ligated magnetic resonance imaging (MRI)
contrast agents26. Fluorescent ligands are especially attractive because of their inherently lower
capital costs, lack of radioactivity and the detailed chemical and structural information that can be
extracted from the spectral properties of a bound molecule. A variety of chemical and
photophysical properties may be desirable in an amyloid fluorescent biomarker. First, the
compound must bind to the amyloid fibril protein conformation with high affinity and specificity.
Compounds that bind specifically to amyloid tend to share a common molecular profile with a
“rigid conjugated rod” morphology; computational studies have shown that linear shape and
aromaticity are favorable for binding to hydrophobic surface grooves in the amyloid fibril27;
similar binding modes have been supported by scanning tunneling microscopy28. Past studies of
amyloid-specific probes have investigated molecular scaffolds derived29 from Congo
red/curcumin30–32, Thioflavin T33–35, oligothiophenes21,36–41, or other scaffolds42–44. These ligands,
when used for fluorescent imaging, primarily function on a “molecular rotor” basis, in which
fluorescence enhancement and emission redshift is accomplished by planarization of the
conjugated region and prevention of rotation within the fluorophore when bound to a planar site
on the amyloid fibril surface. Studies have targeted various properties, such as murine in vivo
imaging, detection of pre-thioflavinophilic amyloids, structural differentiation of amyloids with
different precursors or properties, two-photon imaging or near-infrared excitation and emission.
A useful fluorophore for most applications ex vivo should have optical transitions within
the range of commercially available laser lines and detectors, large extinction coefficient, and
bright, slowly-bleaching fluorescence. For ligand-fluorophores, the most desirable properties are
strong selective binding to the target structure and, ideally, an increase in quantum yield of
fluorescence in the bound vs. free state. The first property, that of selective binding, is already
difficult to tune for, but is primarily the result of sterics, electrostatic and hydrophobic matching
to a target site. The second property is even less well-understood and developed from a design
standpoint, being the result of physically complex properties of ligand electronic structure. This
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project comprised an attempt to integrate both properties following the fortuitous discovery of a
binding-triggered fluorescence yield change associated with desolvation in an ethyl esterfunctionalized subclass of phenylene ethynylene electrolytes.
In 2011, Tang et al45 discovered an unexpected property of their newly synthesized pphenylene ethynylene oligomers: While unfunctionalized p-phenyleneethynylenes had similar
quantum yields of fluorescence in water and in methanol, the molecules with phenylene-attached
ethyl esters had drastically reduced fluorescence yields in water. This property was noted and
given some cursory explanation in their original paper, and subsequently used in self-assembling
sensor systems for various enzymes by Hill46. Through a poorly-understood mechanism, excited
states are able to decay to ground through non-radiative energy transfer to solvent, a process
which is most efficient for H2O and less efficient in less strongly H-bonding solvents. This
solvent-sensitive fluorescent emission property serves as a “desolvation trigger” that lights up the
dye fluorescence upon binding to protein aggregates.

2. Methods
Except OPEs, all reagents were obtained commercially and used without further
purification. Synthesis of OPEs has been reported previously45, except for OPE1-, which was
synthesized analogously to OPE1+. Hen egg white lysozyme (HEWL), Thioflavin T and buffer
components were obtained from Sigma-Aldrich Chemical Company (St. Louis, MO). All water
was purified with a Synergy UV Millipore purification system (EMD Millipore, Billerica, MA).
Suspensions of protein aggregates were gently vortexed to distribute aggregates before use in
experiments.
Lyophilized HEWL was dissolved at 10 mg/mL (700 μM) in 10 mM pH 3 sodium citrate
buffer with 0.1 M NaCl. The solution was incubated in a 70oC oil bath and magnetically stirred at
250 rpm for 12h, and aliquots were withdrawn at half-hour intervals. The initially clear solution
was observed to form cloudy aggregates by 1h of incubation. Half of each aliquot was
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immediately diluted into pH 7.4 phosphate buffer to prevent further influence of acidic conditions
and stored at 4C. The samples were observed to undergo no noticeable degradation over the
course of one month, and these neutralized aliquots were used for all following experiments
except for measurements of protein circular dichroism.
For studies of fluorescence enhancement vs. protein incubation time, dyes were mixed
with protein sample in phosphate buffer (PB, 10 mM, pH 7.4) at an equal monomer concentration
of 10 μM in the wells of a standard 96-well plate. Emission spectra were obtained using a
SpectraMax M2e plate-reading spectrophotometer (Molecular Devices, Sunnyvale, CA).
Experiments were performed in duplicate and errors are reported as standard deviation. For
analysis of bound OPE excitation and emission spectra and protein-OPE energy transfer, OPEs
(500 nM) were mixed with protein sample (5 μM, monomer basis) in PB and the solution
transferred to a quartz fluorometry cuvette. Spectra were obtained on a PTI QuantaMaster 40
steady state spectrofluorometer (HORIBA Scientific, Edison, NJ).
For protein intrinsic circular dichroism, protein samples were diluted in sodium citrate
buffer without NaCl (pH 3, 10 mM) to a concentration of 0.14 mg/mL, gently vortexed, and read
in a 1mm pathlength quartz CD cuvette using an Aviv 410 CD spectrometer (Aviv Biomedical,
Lakewood, NJ) with a 15s averaging time. A blank spectrum (PB only) was subtracted from each
sample to remove background signal. Error bars are standard deviation over multiple reads of a
single sample as reported by the instrument.
For OPE induced circular dichroism, OPEs and protein were diluted in phosphate buffer
(pH 7.4, 10 mM) to an OPE and protein concentration of 5 μM, and data was obtained and
processed identically to the protein CD experiments.
For determination of binding constant of OPEs to amyloid aggregates, OPEs were mixed
with HEWL amyloid in PB at a final OPE concentration ranging from 100 nM to 5 μM and final
protein concentration of 5 μM (monomer basis). The solutions were then transferred to a quartz
fluorometry cuvette and emission measured at the pertinent wavelength. Experiments were
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performed in duplicate and errors reported as standard deviation. Hill function fits to OPE
binding curves were calculated using OriginPro 9.
For AFM, a droplet of each protein sample at 5 mg/mL was pipetted onto freshly cleaved
mica substrate and allowed to physisorb for 20 min, followed by a single rinse with HPLC-grade
water and gentle drying under a stream of N2. Imaging was performed with a Nanoscope IIIa
AFM (Veeco, Plainview, NY) in tapping mode under a constant stream of dry N2 gas using a
rectangular silicon cantilever with a spring constant of 40 N/m (Veeco model RTESPA-W).
Veeco Nanoscope software was used to capture and analyze the images. 0h and 1h images are
cropped from 1 μm width images subjected to a first-order x,y plane fit and flattened. 1.5h image
is cropped from a 5 μm width image subjected to a third-order x,y plane fit and flattened. 4h
image is cropped from a 5 μm width image subjected to a first-order x,y plane fit.
For TEM imaging, incubated HEWL solutions at a concentration of 350 μM were diluted 1:5 in
water and aliquoted onto carbon-coated grids, allowed to adsorb, washed with deionized water
and stained with 2% uranyl acetate solution. Excess liquid was removed and the samples allowed
to dry in air. Samples were imaged on a Hitatchi H7500 transmission electron microscope
(Hitachi High Technologies Corp., Tokyo, Japan) with tungsten filament illumination, operating
with an AMT X60 bottom mount CCD camera detector.

3. Discussion & Conclusions
Oligo(p-phenyleneethynylene) electrolytes (OPEs), which have been previously
investigated along with their polymeric derivatives for a variety47,48 of antimicrobial11,49–51 and
sensing52–55 applications as well as for organic semiconductor devices, have many of the desirable
properties for amyloid biomarkers, such as linear, highly conjugated morphology and several
well-characterized fluorescence sensing effects. In addition to the molecular-rotor motif, OPEs
can form supramolecular aggregates of different types56 with distinct spectral characteristics, such
as J aggregates. J, or Jelley, aggregation is a mode of dye complexation with characteristic
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bathochromic absorbance shifts, sharpened fluorescence bands, enhancement of fluorescence
yield and narrowed Stokes shift. These aggregates have a long history in dye chemistry, and
recent reviews57 can provide more detailed background. The exact structure of J-type aggregates
varies somewhat with the dye and “brickwork,” “ladder,” and “staircase”-type arrangements have
all been proposed57. OPEs with charged moieties pendant on the sides of the phenylene ethnylene
(PE) backbone, rather than the ends, have been previously found to preferentially form J
aggregates when complexed with oppositely charged surfactants56. In addition, ethyl ester termini
have been shown to confer strong excited-state quenching of fluorescence by water: quantum
yield of a cationic OPE with symmetric ethyl ester termini (OPE1+, Figure III.1) increases from
2.3% in water to 5% in deuterium oxide58 and over 75% in methanol45 (Table III.1). This effect
vanishes when the ester is converted to a free carboxylate, and could be due to a hydrogen
bonding or partial proton transfer mechanism58. These various effects give OPEs several distinct
ways to provide spectral information about their environment and conformation, stemming from
the one degree of rotational freedom in the ethynyl-aryl bonds, several different solvent
quenching effects, Coulombic interactions with the charged groups and hydrophobic interactions
with the conjugated backbone. These molecular and optical properties, and their similarity to the
“rigid conjugated rod” morphology, led us to test OPEs as selective optical sensors for amyloids.
In the present study, we selected four OPE molecules (Figure III.1) with ethyl ester termini and
varying charge and number of repeat units, and successfully applied them in vitro as fluorescent
probes specific for model amyloids formed from hen egg white lysozyme.

Figure III.1. Structure and functional groups of OPEs used in this study.
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Four OPEs (Figure III.1) were chosen from our library of compounds for evaluation
against HEWL amyloids. The OPEs used, designated for brevity OPEn+ and OPE1-, all have
ethyl ester terminal moieties on the PE backbone and charged side-pendant groups; the cationic
compounds have n = 1, 2 and 3 repeat units and the anionic compound has one repeat unit. The
compounds are amphiphilic and water soluble due to the hydrophobic backbone and charged side
groups. These ester-terminated compounds were selected for the effective sensing modality of
fluorescence yield increase from reduced quenching by water when bound to a hydrophobic
surface.

Formation and Characterization of HEWL Amyloids

Hen egg white lysozyme (HEWL) was used to form fibrillar amyloid aggregates for use
in this study. Lysozyme has been suggested59 as a useful model protein for amyloid studies, due
to its low cost and the relative ease with which it can be induced to form amyloid aggregates.
Lysozyme amyloid oligomers and fibrils have also been shown to exhibit cytotoxicity towards
human neuroblastoma cells60, indicating that the amyloid-aggregate conformer of lysozyme
recapitulates most of the relevant properties of known disease-associated proteins. For our
experiments, HEWL (Sigma-Aldrich) was incubated at 70˚C and a concentration of 350 μM in
pH 3 sodium citrate buffer (10 mM) with 100 mM NaCl61. Visible precipitates of aggregated
lysozyme were observed to accumulate over the time of incubation, and the formation of amyloid
fibrils was characterized by Thioflavin T (ThT) fluorescence assay, far-UV circular dichroism
(CD) spectroscopy, and atomic force microscopy (AFM) and transmission electron microscopy
(TEM).
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Figure III.2. OPE and Thioflavin T (10 μM) fluorescence enhancement profiles of HEWL
incubated for various times (10 μM monomer basis, 0.5 mg/mL), with unbound dye fluorescence
normalized to 0 and maximum dye fluorescence normalized to 1.

Figure III.3. Far-UV circular dichroism spectra of 0h, 2h and 4h incubated HEWL (0.14 mg/mL)
in pH 3 citrate buffer (10 mM).
ThT-positive aggregates were detected by the second hour of incubation (Figure III.2),
and the profile of ThT fluorescence enhancement over incubation time had the sigmoidal shape
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consistent with the nucleation-controlled aggregation mechanism that is well accepted for
amyloid formation. Far-UV CD measurements (Figure III.3) showed conversion of primarily αhelix structure of monomeric lysozyme (0h), as indicated by the negative bands at 222 and 208
nm, into primarily β-sheet structure in the mature aggregates (2h and 4h), as indicated by the
single negative band at 218 nm and the positive band just visible at the 200 nm edge of the
spectrum62.

Figure III.4. TEM (top) and AFM (bottom) images of 0h (a), 1h (b), 1.5h (c) and 4h (d) incubated
HEWL. Scale bars = 200 nm. 4h, inset: view of a single fibril, showing a twisted morphology.
AFM image Z-height: 0h, 25 nm; 1h, 25 nm; 1.5h, 15 nm; 4h, 100 nm.

Fibrillar morphology of HEWL aggregates was visualized directly by AFM and TEM.
AFM on dry mica and TEM (Figure III.4) on non-glow discharged carbon grids showed that
unincubated HEWL (0h, Figure III.4a) formed a homogeneous film without large features. One
hour of incubation (Figure III.4b) caused the HEWL to form distinguishable bumps, hypothesized
to be pre-thioflavinophilic oligomers. By 1.5 hours of incubation when amyloid formation was
just reaching the plateau phase as indicated by ThT fluorescence (Figure III.2), small linear
aggregates were observed (Figure III.4c), which lengthened by the fourth hour into short, bundled
fibrils 20-30 nm wide and 60-200 nm long (Figure III.4d). No fibrils significantly longer than
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these were observed, even for longer incubated samples. These fibrillar, β-sheet enriched, ThTpositive HEWL amyloid aggregates were then used to evaluate the binding activity and
photophysical changes of OPEs against amyloid.

Spectrophotometry of OPE-HEWL Interactions
Excitation and emission spectra of OPEs in phosphate buffer (PB) alone, with monomeric
HEWL and with HEWL amyloids (8h incubated) are shown in Figure III.8, and relevant
photophysical properties are summarized in Table 1. A 10:1 molar ratio of protein to OPE was
used for these experiments. Absorbance spectra were also taken (Figure III.5) but background
light scattering from insoluble amyloid aggregates made them difficult to interpret, so
“fluorescence detected absorbance” in the form of excitation spectra was used instead.
Normalized excitation and emission spectra, in which peak shifts and lineshape changes of
spectra are easier to visualize, are provided in the Supporting Information (Figures III.6 and
III.7). All four OPEs exhibited significant fluorescence enhancement in solution with HEWL
amyloids (Figs. III.8e, f, g, h), and no fluorescence change with HEWL monomers except for
OPE1-. The fluorescence enhancement over baseline was most significant for the longer OPE2+
and OPE3+ (Figs. III.8g and h), which also had notably sharpened fluorescence spectra with
small (~10 nm) blueshifting of the maximum (Figure III.7). OPE1- had a similarly sharpened and
blueshifted emission spectrum (Fig. III.8f and III.7) with both HEWL monomers and amyloid,
with the appearance of a shoulder at 465 nm with amyloid. OPE1+ (Fig. III.8e) exhibited no
change in wavelength or lineshape of emission spectrum, just a large increase in intensity when
mixed with amyloids. The excitation spectra (Figs. III.8a, b, c, d) show a notable bathochromic
shift for each OPE in solution mixed with amyloid, of 23, 27, 35 and 29 nm of the low-energy
band for OPE1+, OPE2+, OPE3+ and OPE1-, respectively. The high-energy band, less relevant
for imaging purposes, was also bathochromically shifted. Very small to no changes in excitation
and emission were observed for the cationic OPEs when mixed with monomeric HEWL. The
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anionic OPE1- had similar excitation spectrum (Fig. III.8b) when mixed with monomer and
amyloid, except for a moderate increase in intensity with amyloid.

Figure III.5. Absorption spectra of OPE3+ (left) and OPE1- (5 μM) in PB alone (long
dashed black line) with HEWL monomer (0.25 mg/mL) (short dashed red line) and with
HEWL amyloid (9h aggregates, 0.25 mg/mL) (solid blue line). Scattering from insoluble
aggregates appears as a large “white” absorption that obscures spectral features. Peak at
280 nm is HEWL native absorption.
a

c

b

d

Figure III.6. Normalized excitation spectra of OPEs (a: OPE1+, b: OPE1-, c: OPE2+, d:
OPE3+). Long dashed black line: OPE in PB alone. Short dashed red line: OPE in PB w/
HEWL monomers. Solid blue line: OPE in PB w/ HEWL amyloid (9h). OPE
concentration = 500 nM, protein concentration 5 μM monomer basis / 0.25 mg/mL.
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a

b

c

d

Figure III.7. Normalized emission spectra of OPEs (a: OPE1+, b: OPE1-, c: OPE2+, d:
OPE3+). Long dashed black line: OPE in PB alone. Short dashed red line: OPE in PB w/
HEWL monomers. Solid blue line: OPE in PB w/ HEWL amyloid (9h). OPE
concentration = 500 nM, protein concentration 5 μM monomer basis / 0.25 mg/mL.
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Quantum Yield
Comp.

φfla

Excitation
Wavelengths
λex (nm)

Emission Wavelength

Hill
K

λem (nm)

Coeffi.
(μM)

PB with
HEWL
amyloids

H2O

PB

PB with
HEWL
amyloids

314,
362

332, 385

454

454

454

2.63 ±
0.58

1.04

0.71

330,
399

337, 426

448

460

445

1.15 ±
0.26

1.15

0.069

0.70

340,
399

335, 434

440

464

453

0.858
±
0.058

1.89

-

-

314,
370

327, 399

454

454

439b

-

-

H2O

MeOH

PB

OPE1+

0.023

0.75

OPE2+

0.039

OPE3+

OPE1-

n

Table III.1. Relevant photophysical properties of OPEs alone and bound to HEWL amyloid, and
apparent binding constants (K) and Hill coefficients (n) of OPE binding to HEWL amyloid.
a
From a previous study56. bSame maximum with monomer and amyloid, with the addition of a
shoulder ~465nm with amyloid.
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Figure III.8. Excitation (left; a, b, c, d) and emission (right; e, f, g, h) spectra of OPES (a, e:
OPE1+; b, f: OPE1-; c, g: OPE2+; d, h: OPE3+) in phosphate buffer (PB, pH 7.4, 10 mM) alone
(black long dashed line) with HEWL monomers (red short dashed line) and with HEWL amyloids
(blue solid line). OPE concentration: 500 nM, protein concentration: 5 μM monomer basis / 0.25
mg/mL. Emission and excitation wavelengths, respectively, were chosen as shown in Table III.1
for each sample.
A plot of normalized fluorescence enhancement for all four OPEs and Thioflavin T with
HEWL fibrils incubated for different lengths of time is shown in Figure III.2. At a 1:1
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protein:OPE molar ratio, OPE1+ and OPE2+ track amyloid formation in roughly the same way as
ThT, showing a sigmoidal curve with onset of a logarithmic growth phase occurring at the same
time, around 1h of incubation. The plateau phase, as monitored by fluorescence of any of those
three OPEs or ThT, appeared at 2 hours incubation. OPE3+ fluorescence enhancement shows a
similar length lag phase but a less sharp growth phase, taking up to 3.5 hours to reach its plateau
phase. At the equimolar concentrations used for this assay, OPE1- has greater fluorescence
enhancement when mixed with monomeric species than with amyloid, giving it a profile that is
the reverse of those observed for the cationic OPEs or ThT; this effect will be discussed below.

Determination of OPE/Amyloid Binding Constants
Next, binding saturation assays were conducted to quantify the affinity of OPE-amyloid
binding; data and fitted curves are shown in Figures III.9 and III.10 and the fitted parameters are
summarized in the last two columns of Table III.1. Since the linear fibril binding sites could
potentially fit many OPEs, binding curves were fitted to the Hill equation to capture possible
binding cooperativity:
𝑦=

𝐹𝑚𝑎𝑥 𝑥 𝑛
𝐾𝑛 +𝑥 𝑛

(Equation 1)

where, y is OPE fluorescence intensity, x is OPE concentration (protein concentration was fixed
in these assays), Fmax is OPE fluorescence intensity at saturation, K is the equilibrium dissociation
constant and the exponential term n is the Hill parameter which describes cooperativity of
binding63. n=1 indicates non-cooperative, independent binding, n>1 indicates that the binding of
one ligand increases affinity of the binding of a second (positive cooperativity), and n<1 indicated
that binding of one ligand decreases affinity of the binding of a second (negative cooperativity).
Fits to the data for the three cationic OPEs produced Fmax values close to the observed
fluorescence saturation values, and fitted values of the other two parameters, K and n, are
reported in Table III.1 as calculated. The fits indicated that OPE1+, OPE2+ and OPE3+ bound to
HEWL amyloid with low micromolar affinity dependent on OPE length, with the calculated
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dissociation constant decreasing from 2.6 μM for OPE1+ to 1.15 μM for OPE2+, and still further
to 858 nM for OPE3+. Furthermore, the cooperativity of OPE binding increased from almost no
cooperativity for OPE1+ (n=1.04), to some positive cooperativity for OPE2+ (n=1.15), to still
more positive cooperativity for OPE3+ (n=1.89). The quantitative physical meaning of the Hill
parameter is not quite clear except in special cases, but in a general way it is possible to conclude
that for the cationic OPEs, the shortest OPE has non-cooperative binding to HEWL amyloid (i.e.,
Michaelis-Menten binding), and the two longer OPEs have increasingly positively cooperative
binding.
Because the anionic OPE1- showed fluorescence changes with both monomeric and
fibrillar HEWL, binding assays were conducted for both conformers of HEWL. In contrast to the
binding curves of cationic OPEs, the binding of anionic OPE1- to HEWL monomers appeared to
be linear and non-saturable for up to 10 μM OPE concentration, or a 2:1 OPE:HEWL molar ratio,
indicating a low-affinity binding to a very large number of sites. Non-specific OPE1- binding to
HEWL monomers precluded accurate determination of a binding constant for OPE1-/amyloid
interactions (Supporting Information Figure III.10) such that quantitative comparisons of binding
between the cationic and anionic compounds cannot be made.
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b

a

c

Figure III.9. Saturation binding assay curves for OPE1+ (a), OPE2+ (b), and OPE3+ (c). Protein
concentration (9h aggregates): 5 μM monomer basis / 0.25 mg/mL. Fits to the Hill equation were
carried out in OriginPro 9 without constraining any parameters. Experiments were performed in
duplicates and error bars represent standard deviations.
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a

b

Figure III.10. a: Linear (non-saturable) binding of OPE1- to HEWL monomers (5 μM / 0.25
mg/mL). Linear fit shown for clarity. This experiment was performed once. B: Attempted binding
assay of OPE1- to HEWL amyloid, showing effect of non-specific binding to monomers.

Induced Circular Dichroism of OPE-Amyloid Complexes

Figure III.11. Circular dichroism spectra of OPEs in PB with HEWL monomer (black trace) and
with HEWL amyloid (red trace). (a): OPE1+; (b): OPE1-; (c): OPE2+; (d): OPE3+. OPEs 10 μM,
HEWL 10 μM monomer basis / 0.5 mg/mL.
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Twists are often observed in mature amyloid fibrils, including HEWL fibrils prepared in
this study (Figure III.4d, inset). This twist or other intrinsic chirality of the HEWL molecule
might induce chirality in bound ligands. To test this hypothesis and gain further insights into the
structure of bound OPE states, CD measurements were taken in the OPE absorbance range to
determine if the intrinsic chirality of the HEWL fibrils was transferred to the OPE chromophore
by a chiral backbone twist or an “excitonic” chiral supramolecular aggregate. CD spectra (Figure
III.11) indicated that OPEs became optically active when bound to HEWL amyloids, as shown in
Figure III.11. As expected, no OPE had optical activity by itself in phosphate buffer solution and
non-binding cationic OPEs were not optically active with HEWL monomers. OPE1-, which did
appear to bind to monomers, though somewhat weakly, also had no optical activity. OPE1+ did
not have optical activity with HEWL amyloid, but the other three OPEs did. OPE1-, OPE2+ and
OPE3+ all had strong induced CD with a negative Cotton effect when bound to HEWL amyloid
fibrils. OPE2+ and OPE3+ gave rise to similar CD spectra, with more intense bands in the
spectrum for OPE3+. The induced CD spectrum for OPE1- had a pronounced two-band structure,
reflecting the more intense high-energy band for the anionic OPE when bound to HEWL
amyloid.
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ProteinOPE Energy Transfer in OPE-Amyloid Complexes

Figure III.12. HEWLOPE FRET efficiencies calculated from spectral data (Supporting
Information) by Equation 1. Data from control experiments can be found in Supporting
Information.

Figure III.13. Fluorescence spectra of OPEs mixed with HEWL monomers showing a lack of
energy transfer from HEWL monomer to OPE as no OPE fluorescence in the 400-550 nm range
was observed.
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a

b

c

d

Figure III.14. Emission spectra of OPEs (a: OPE1+, b: OPE1-, c: OPE2+, d: OPE3+) (500 nM) in
PB with HEWL amyloid (9h aggregates, 5 μM monomer basis / 0.25 mg/mL) excited at 280 nm.
Low wavelength peak (300-375 nm) is lysozyme native fluorescence and the high wavelength
peak (400-550nm) is OPE fluorescence.

Since lysozyme is an intrinsically fluorescent protein whose emission spectrum in the
320-380 nm wavelength range overlaps significantly with the excitation spectra of OPEs (Figure
III.13), we investigated the possibility of Förster resonance energy transfer (FRET) from the
protein chromophore to OPEs by a simple spectroscopic method. Emission spectra of solutions
containing OPEs and HEWL amyloids or monomers were obtained using the excitation
wavelength of HEWL (280 nm) and OPE emission was observed only from OPE/amyloid
samples, indicating that HEWLOPE energy transfer was occurring only with OPEs bound to
amyloid fibrils. The results are summarized as FRET efficiencies (E) in Figure III.12. The raw
spectral data (Figure III.14) was converted to efficiencies by the equation

𝐸=

𝐹𝐴
𝐹𝐷 +𝐹𝐴

(Equation 2)
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where FD is the integrated area under the donor emission peak, and FA is the integrated area under
the acceptor emission peak. This simple expression is valid for this case since the OPEs are
nonfluorescent when excited at the donor excitation wavelength of 280 nm, eliminating crosstalk.
Thus, FA is the total number of energy transfer events, and (FA+FD) is the total number of
excitation events. Theoretically, the efficiencies should be convertible into distances by

𝐸=

1
𝑟 6
)
𝑅0

1+(

, (Equation 3)

However, because OPEs and HEWL amyloids are not a well-characterized FRET pair with a
defined Förster radius R0, and calclulating R0 for a protein-ligand pair not freely rotating relative
to each other in solution is rife with inaccuracies2, we cannot directly evaluate distances in the
OPE-HEWL system. Qualitiatively, we can make some determinations based on the relative
measured efficiencies for the different OPEs. The measured FRET efficiency will be affected by
multiple independent factors averaged over all the OPE-HEWL pairs in solution, such as the
number of bound OPE molecules, the bound OPE-HEWL chromophore distance, and the spectral
overlap integral J(λ), all of which will vary by OPE. The highest apparent efficiency observed for
OPE2+ is probably the result of its higher binding constant than OPE1- or OPE1+ combined with
its greater overlap integral than OPE3+.
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a

b

Figure III.15. a: Control experiments showing that OPEs alone are non-fluorescent when excited
at 280 nm. B: Emission spectra of 0h (black solid line), 1h (red long dashed line), 2h (blue short
dashed line) and 4h (green dot-dashed line) incubated HEWL, λex=280nm, showing reduction in
intrinsic protein fluorescence over the process of amyloid formation.

Explicating the Mode of OPE-Amyloid Binding

Figure III.16. Illustration of proposed binding modes of OPEs to HEWL monomers and amyloid
fibrils.
The results of these experiments led us to hypothesize modes of interaction between
OPEs and HEWL monomers and amyloids, as illustrated in Figure III.16. All four OPEs tested
were observed to bind to HEWL amyloid, with good affinity, but with different properties
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depending on chain length and charge. Generally, the OPEs either do not interact with protein,
bind as single molecules, or bind as J dimers which are either racemic or chirally biased. The
changes in the excitation spectra of OPE2+ and OPE3+ when bound to amyloid are also highly
reminiscent of the absorbance spectra observed for the same compounds when complexed with
carboxymethylcellulose45. Overall, it has become clear that J-type aggregation is a naturally
favorable mode of OPE-OPE interaction for OPEs with charged side chains when the Coulombic
repulsion between the charged groups is reduced.
The spectral changes of OPE2+, OPE3+, and OPE1- in complex with HEWL amyloids,
and of OPE1- in complex with HEWL monomers, are highly indicative of J aggregation:
redshifted absorbance, sharpening of fluorescence band, and narrowed Stokes shift. The
enhancement of fluorescence intensity is attributable all or in part to the reduced quenching of the
OPE by water when bound to the hydrophobic sites on the surface of the protein; this solventaccess effect is in play for all four OPEs. The current study indicates that the longer cationic
OPEs, OPE2+ and OPE3+, form J dimers (or possibly larger aggregates) on the HEWL amyloid
fibril surface, and OPE1- forms J dimers on both HEWL monomers and HEWL amyloid fibrils.
The OPE aggregates formed on amyloid fibrils have a chiral bias to the OPE-OPE offset angle,
producing a chiral supramolecular chromophore, or an excitonic optical activity, responsible for
the circular dichroism seen experimentally (Figure III.11). The exact source of this bias is hard to
pin down; it could be a result of the helically twisted fibril axis (see Figure III.4d, inset) or more
specific to a binding site. Notably, the aggregates formed by OPE1- must be racemic, indicating
that the OPEs are not interacting with a specific site but simply binding to oppositely charged
residues on the lysozyme surface. OPE1+ exhibited some small redshifts in the excitation
spectrum, but its emission spectrum does not shift at all and it acquires no optical activity,
indicating that this compound binds to HEWL fibrils as single molecules rather than as a
structured aggregate. The small excitation redshift could be due to minor backbone planarization,
and the increase of fluorescence intensity to reduced solvent access.

34
The results of binding saturation assays support these conclusions for the cationic OPEs.
OPE2+ and OPE3+ show positive cooperativity, meaning that the binding of one OPE increases
the affinity of the next binding event. The formation of J aggregates on the fibril surface satisfies
this condition: a single OPE might bind to a favorable site, and a second finds it and forms an
even more favorable J aggregate due to π-π and hydrophobic interactions. It is also possible that
OPEs could form J dimers in solution that subsequently find the fibril surface, but this seems
unlikely due to charge repulsion. Furthermore, the binding curve for OPE3+ shows a larger
cooperative effect than that for OPE2+, and the induced CD bands for OPE3+ are also more
intense; the increased length of OPE3+ increases the available area for aggregate formation,
forming more or larger chiral aggregates. The OPE1+/HEWL amyloid binding assay indicated no
cooperative binding effect, which is consistent with independent, single-molecule binding. The
decrease of apparent dissociation constant K with increasing OPE length is in agreement with the
results of previous studies indicating that longer linear conjugated regions increase affinity for a
long hydrophobic binding site on amyloid27.
One notable result of this study is the large differences between OPE1+ and OPE1- in
their interactions with HEWL monomers and amyloid, as shown in Figure III.16. These two
single-repeat OPEs tested differ only by the charge on the side-pendant solubilizing groups
(Figure III.1), and their interactions with HEWL monomer and amyloids were highly different.
OPE1+ exhibited non-cooperative and saturable binding to amyloid fibrils without induced
optical activity or large shifts in absorption or emission bands, and when bound, its emission was
the least enhanced over free OPE. Its anionic counterpart, OPE1-, proved quite different both in
its nonspecific binding to HEWL monomer and in its interaction with HEWL amyloid. The
interaction of OPE1- with HEWL monomers has been noted in an analogous system, with
sulfonate-bearing p-phenyleneenthynylene polymers64, and is mediated by hydrophobic and
electrostatic interactions with the positively charged (at neutral pH) lysozyme. This interaction
was seen to be fairly weak and non-specific, as indicated by the non-saturable binding, but it
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overwhelms the OPE1-/amyloid interaction at high OPE concentrations, after all the amyloid
binding sites are occupied. In vitro, without interfering effects from other cellular/tissue
components, such an effect could prove useful for monitoring the disappearance of similarly
charged monomers. The differences in the OPE1+ and OPE1- binding to amyloid—OPE1+ binds
singly and OPE1- as chiral J aggregates—could be due to charge or H-bonding interactions
specific to sites on the lysozyme fibril surface. The specificity of these possible charge effects is
notable, since the arrangement of charged residues on the fibril surface is controlled by the
protein's primary, secondary and tertiary structures. This effect could provide useful means of
differentiating amyloids formed from different monomers.
Analysis of the energy transfer from HEWL amyloids to OPEs corroborates many of
these proposed binding modes. The absence of FRET in any monomer/OPE solution reconfirms
the weak and non-specific nature of OPE1-/monomer binding, since the OPE is not held within
range of the fluorescing aromatic residues. In natively folded conformations of globular proteins
such as lysozyme, hydrophobic residues are typically buried in the hydrophobic interior of the
protein and not solvent, or ligand, accessible. Aromatic residues may also only be surface
exposed, available for binding, and within range of FRET to OPEs in the amyloid state; HEWL
intrinsic fluorescence is found to decrease over the course of incubation (Figure III.15b), which
implies that the fluorescing residues are increasingly exposed to solvent quenching as more
amyloid forms. The very strong distance dependence of FRET effects (typically <10nm) 2,65
provides a strong constraint on the possible location of OPE fluorophores on the fibril surface.
When combined with computational simulations, this FRET effect could shed some light on the
molecular structure of other, more closely disease-related amyloid-forming proteins with intrinsic
fluorescence.
Our results, especially the effects of ligand charge, are clearly influenced by the primary
sequence of the protein monomer used to form amyloid. Performing future work with diseaserelated amyloid proteins and peptides, and ideally with sections of actual diseased tissue or in
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well-characterized animal models, is critical to developing OPEs, or other molecules, into viable
tools for researchers and, eventually, clinicians. The large differences between OPE1+ and OPE1's interactions with monomeric and amyloid HEWL, likely influenced by specific charged
residues in the HEWL primary sequence, seem promising for differentiating amyloids formed
from different protein monomers, a useful effect, for example, in the study of dementia with
Lewy bodies66, in which Lewy bodies (formed of the protein alpha-synuclein and normally
characteristic of Parkinson's disease) and amyloid plaques are comorbid.
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IV. Broader Testing of OPE/PPE Library with Two Model
Amyloids
1. Background
After testing a small subgroup of OPEs as amyloid detection agents, found them to be
effective, and developed some hypotheses as to the molecular mechanisms underlying their
effectiveness, the next step was to challenge our assumptions by testing a larger library of OPEs
and PPEs using more model amyloids. The previous project had focused only on ethyl esterbearing OPEs, but the necessity of this moiety for sensor function had not been determined. The
“steric targeting” property had also to be determined empirically by testing the pre-existing ligand
library against various types of amyloids. Furthermore, the model amyloid system had to be
expanded to include another type of protein monomer.

2. Methods
Except OPEs, all reagents were obtained commercially and used without further
purification. Synthesis of OPEs has been reported previously45, except for OPE1-, which was
synthesized analogously to OPE1+. Hen egg white lysozyme, bovine insulin and Thioflavin T
were obtained from Sigma-Aldrich Chemical Company (St. Louis, MO). Suspensions of protein
aggregates were gently vortexed to distribute aggregates before use in experiments.
To make amyloids, HEWL was dissolved at 5.46 mg/mL in an acidic buffer (10 mM
sodium citrate, pH 3, 0.1 M NaCl) and incubated at 70oC for 12h with 250 rpm magnetic stirring.
For insulin fibrils, a 10 mL stock solution of insulin was prepared at 10 mg/mL in pH 3 citrate
buffer, with a drop of HCl added to solubilize the protein, and the stock was diluted to 5.46
mg/mL and incubated under the same conditions as HEWL. Extinction coefficients at 280 nm of
1.0 L/g*cm for insulin67 and 2.63 L/g*cm for lysozyme68 were used to determine concentrations.
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Both protein solutions, initially clear, formed a cloudy precipitate within an hour of heating. For
thioflavin T assay, protein and ThT stock were mixed in PB to a final concentration of 5 ug/mL
protein and 20 uM ThT and emission spectra obtained with 440nm excitation and 480nm
emission.
For AFM, a droplet of each protein sample at 5 mg/mL was pipetted onto freshly cleaved
mica substrate and allowed to physisorb for 20 mins, followed by a single rinse with HPLC-grade
water and gentle drying under a stream of N2. Imaging was performed with a Nanoscope IIIa
AFM (Veeco, Plainview, NY) or Asylum Research MFP-3D-BIO in tapping mode under a
constant stream of dry N2 gas using a rectangular silicon cantilever with a spring constant of 40
N/m (Veeco model RTESPA-W).
Spectroscopic assays were conducted as follows. In the wells of a 96-well plate,
monomeric protein, amyloid or a buffer blank was diluted with CPE stocks into 10 mM pH 7.4
phosphate buffer to a final concentration of 2 uM OPE or 1.88 ug/mL PPE (same monomer
concentration as the intermediate-size OPEs) and 5 ug/mL protein. The plates were then read on a
plate-reading spectrophotometer (SpectraMax M2e, Molecular Devices, Sunnyvale, CA) for
absorption and emission spectra. Final sample volume was 200 uL, and each well was prepared in
duplicate. For more detailed evaluation of spectral changes, a steady-state cuvette-reading
fluorimeter (PTI QuantaMaster 40, HORIBA Scientific, Edison, NJ) was used. The same
concentration and sample volumes were prepared and transferred to a small-volume quartz
fluorimetry cuvette (Starna Cells, Atascadero, CA), and excitation and emission spectra were
obtained.
For protein intrinsic circular dichroism, protein samples were diluted in sodium citrate
buffer without NaCl (pH 3, 10 mM) to a concentration of 0.14 mg/mL, vortexed briefly, and read
in a quartz CD cuvette (1mm pathlength) using an Aviv 410 CD spectrometer (Aviv Biomedical,
Lakewood, NJ) with a 15s averaging time. A blank spectrum (buffer only) was subtracted from
each sample to remove background signal. Error bars are standard deviation over multiple reads
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of a single sample as reported by the AVIV software. For OPE induced circular dichroism, OPEs
and protein were diluted in phosphate buffer (pH 7.4, 10 mM) to an OPE and protein
concentration of 5 μM, and data was obtained and processed identically to the protein CD
experiments. OPEs and protein samples were diluted in phosphate buffer, gently vortexed, and
read in a 1mm pathlength quartz CD cuvette using an Aviv 410 CD spectrometer (Aviv
Biomedical, Lakewood, NJ), 15s averaging time. A blank spectrum (PB only) was subtracted
from each sample to remove background activity. Error bars are standard deviation over multiple
reads of a single sample as reported by the instrument.
For binding constant determinations, matured fibrils were first separated from residual
monomeric and smaller aggregated proteins by repeatedly passing diluted solutions through
Amicon centrifugal filter units (EMD Millipore, Billerica, MA) having a 30 kDa molecular
weight cutoff. The concentration of the resulting fibril concentrates was determined by
absorbometry at 280 nm. OPE/fibril solutions were prepared with 500 nM protein concentration
and a range of OPE concentrations, read on the spectrofluorometer, the peak fluorescence plotted
against ligand concentration and the curve fit to the Hill equation in OriginPro 9 without
constraining any parameters.

3. Discussion
This project evaluated the binding-activated photophysical changes to the members of a
library of poly- and oligo(phenylene ethynylene) electrolytes upon interaction with lysozyme and
insulin model amyloids. The compounds in the screening set are detailed in Table IV.1. This set
comprised 18 different phenylene ethynylenes, thiophene ethynylenes, and one phenylene
ethynylene-thiophene ethynylene copolymer, with solubilizing cationic and anionic groups
attached on the sides or ends of the backbone. The compounds bearing ethyl ester substituents
were predicted to exhibit much better sensing activity due to their possession of a solvation-
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triggered nonradiative decay pathway, but we chose to evaluate all the compounds to test for
possible alternate binding-triggered mechanisms such as molecular-rotor behavior.28,69

Backbone

Substituents

Cmpd.
A1
A2
A3
n=1
n=2
n=3
n=1
n=2
n=3

B1
B2
B3
B4
OPE2
B5
B6
B7

n=1
OPE1

C1
C2
C3
n > 1000

C4

C5
C6

Table IV.1. Table of compounds tested against model amyloids.
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Figure IV.2. AFM and circular dichroism of protein preparations confirming the presence of
linear, beta-sheet enriched aggregates. Top: lysozyme; bottom: insulin.
Preparation of model amyloids was performed using literature procedures.70,71 Lysozyme
and insulin were chosen for their well-studied amyloid-forming properties and differing charge
distributions at neutral pH, and amyloids were formed simply by heating the protein in acid.
Amyloids were prepared by incubation of protein solutions at 70oC and a buffered pH of 3. FarUV circular dichroism spectroscopy (Figure III.2) indicated transformation of the primarily
alpha-helical native secondary structures of both proteins into the beta-sheet structure indicative
of amyloids. Atomic force microscopy of incubated protein solutions deposited on mica (Figure
III.2) revealed that both proteins formed bundled, short fibrillar aggregates, with individual linear
structures about 100 nm long and 20 nm wide, composed of two or more twisted sub-fibrils.
These amyloid aggregates also tested positive using the gold-standard thioflavin T binding assay.
Taken together, under high heat and acidic conditions, both model amyloid proteins readily
formed fibrillar, beta-sheet enriched aggregates that are thioflavin-T positive.
Testing of candidate dyes against model amyloids was performed by spectrophotometry
of dilute solutions of dye alone, dye with monomeric protein, and dye with aggregated protein.
After taking emission spectra of each candidate dye in buffered solution, with monomeric protein
and with amyloid fibrils, we defined a dimensionless quantity Q as described in Equation 1:
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𝑄=

𝐹+𝑓𝑖𝑏𝑟𝑖𝑙 −𝐹+𝑚𝑜𝑛𝑜𝑚𝑒𝑟
𝐹𝑏𝑢𝑓𝑓𝑒𝑟

(Equation 1)

Where 𝐹+𝑓𝑖𝑏𝑟𝑖𝑙 , 𝐹+𝑚𝑜𝑛𝑜𝑚𝑒𝑟 or 𝐹𝑏𝑢𝑓𝑓𝑒𝑟 indicates the integrated emission intensity for the dye
under the relevant condition. Figure III.3 summarizes the Q values measured for each dye in the
screening set. Values of Q close to zero indicate that the dye failed to differentiate between
fibrillar and monomeric protein, negative values indicate that the dye interacted strongly with
monomeric protein, and positive values indicate that the dye selectively detected amyloid
conformations.

Figure IV.3. Chart of detection response values, calculated from fluorescence data using Equation
1 for each dye in the screening set. Error bars are SEM.
The values shown in Figure III.3 indicate that the COOEt-terminated compounds gave
the greatest changes in fluorescence yield upon interaction with protein, and moreover that the
only compound with effective sensor response to amyloid (defined as positive Q for both
lysozyme and insulin amyloid i.e. specificity for the amyloid conformer over monomeric protein)
was OPE1.
Despite the large solvent-sensitive emission yield and favorable morphology of the Hsubstituted dyes, their performance as amyloid-detecting ligands was poor. Binding to amyloid, if
it occurs, fails to stabilize a planar configuration of the backbone in singly bound dye, resulting in
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a dark bound state. By contrast, the ester-substituted dyes are sterically shielded from solvent
access in the bound state, resulting in significantly increased fluorescence upon binding.
Disentangling rotational internal conversion from self-quenching by aggregates from solventmediated quenching is exceptionally difficult in systems of amphiphilic dyes, but substantial
circumstantial evidence favors the interpretation that fluorescence of phenylester OPEs is
suppressed in water by a mechanism that is not intramolecular rotational internal conversion, not
least of which being that computational results show planar lowest-energy ground and excited
states.72 Additionally, if quenching process in the COOEt molecules is rotationally based, then we
would expect to see increased fluorescence yield in water, with the increased solvent-ester Hbonding interactions increasing drag on the rotation of the terminal phenyl ether.73

CD Signal
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Figure IV.4. Fluorescence excitation and emission spectra (top) and circular dichroism spectra
(bottom) of OPE1 in buffer solution and bound to amyloids.
Contrary to our expectations, polymeric dyes did not perform effectively as dyes for any
type of amyloid. Despite their great length, our previous observation of positive correlation
between molecular length and amyloid binding affinity, and differences in emission yield
depending on the state of self-aggregation, the effectiveness of these conjugated polyelectrolytes
was low. Possibly chain-chain interactions along the polymer are too strong to be overcome by
the binding to amyloid. Even previous groups to have explored polyelectrolyte dyes for amyloid74
have since moved to small-molecule derivatives for better controllability, effectiveness and intissue transport properties. The smallest compounds tested, the linear end-functionalized dyes A1,
A2 and A3, were also completely ineffective as amyloid sensors due to their binding to
monomeric protein. These compounds, as mentioned above in Project I, have previously been
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shown to interact with the membranes of Gram-positive and –negative bacteria and disrupt them.
This non-amyloid-specific intercalative mechanism is a significant drawback.
Along with desolvation-triggered dequenching, the second mechanism involved in the
fluorogenic performance of OPE1 is the formation of luminescent, protein-templated Jaggregates. J-aggregates have a long history in the chemistry of organic dyes and are defined as
aggregates with hypsochromic (red-shifted) absorbance bands, increased fluorescence yield and
decreased Stokes shift compared to monomeric dye57. The controlled aggregation of phenylene
ethynylenes has been exploited before to engineer solution-phase sensor systems, and is a useful
way to control analyte-sensitive changes in optical properties. The formation of aggregates in
amyloid-templated OPE systems is indicated by J-type changes in spectral properties and the
broken symmetry (as indicated by induced circular dichroism) of the amyloid-bound OPE
absorption band. In the amyloid-bound OPE1, absorption maxima are observed to redshift and
fluorescence band narrows and increases in brightness (due also to the reduction of solvent
quenching), indicating the formation of J-type aggregates. Similar spectroscopic changes are
observed in surfactant/dye systems, as well as complexes of dyes with carboxymethylcellulose,
hypothesized to contain J-aggregates.45,56 OPE1 also develops induced circular dichroism when
bound to amyloid, which could be due to chiral backbone twisting but is more likely due to the
formation of stacked J-aggregates in short chiral helices. If chiral backbone twisting was
responsible for the strong induced CD signal, the reduction in mean chromophore length would
appear as a significant blueshifted band, which is not observed.

4. Conclusions
The results of this project show that oligo(p-phenyleneethynylene) electrolytes are an
effective molecular scaffold for selective sensing of the amyloid fibril conformer of the model
protein HEWL. OPEs exhibit drastic fluorescence enhancement and useful absorbance redshift
when introduced to the HEWL amyloid conformer, and binding constants were determined to be
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usefully low, ~1 μM. Furthermore, the amyloid-sensing properties—fluorescence enhancement,
cooperative binding and induced optical activity—are hypothesized to be due to the propensity of
the dye molecules to form chiral, superluminescent J aggregates templated on the amyloid fibril
surface. Although the OPEs used in this study were not designed or optimized for amyloid
binding, they still performed effectively compared to Thioflavin T, the amyloid dye currently in
widest use. The fluorescence properties and optical activity of the bound OPEs are highly
dependent on OPE chain length and charge. The longer, cationic OPEs are the most promising
ligands for imaging purposes among the molecules tested in this study. OPE2+ and OPE2+, in
particular, have low enough apparent binding constants and optical bandgap to possibly be used
immediately for ex vivo staining. On a molecular level, several effects are probably at work,
including restriction of internal rotation, planarization, reduction of quenching by water and Jtype aggregation. For all four OPEs, reduction of quenching by water when bound to the
hydrophobic site is responsible for some of the drastic fluorescence enhancement.

47

IV. Sensing in a Tissue Environment: Sensing of Amyloids
II
1. Background
Having established the efficacy in vitro of small linear phenyleneethynylene electrolytes
in both selectively binding to amyloid conformers and undergoing a desolvation-triggered
increase in fluorescent yield, a logical next step was to evaluate their extensibility to the much
more complex and crowded environment of fixed animal tissue. Formalin-fixed brain sections
present many sites of competitive binding and places for the dye to “get stuck,” and performance
and selectivity in this environment is a crucial test.

2. Methods
Tissue sections were prepared with the help of Dr. Kiran Bhaskar and Nicole Maphis at
the MIND Institute at UNM Health Sciences Center. Tissue used was from 9-month-old rTg4510
human tau-expressing mice, two-month-old B6 wild-type laboratory mice, or 20-month-old
R1.40 mice expressing human amyloid precursor protein with Swedish mutation and human
presenilin with familial mutation.75 Tissue was already sectioned at the time of experiment and
stored in cryoprotectant solution. Previous to our experiments, mice were anaesthetized,
sacrificed with CO and transcardially perfused with phosphate buffered saline. After dissection,
whole brains were fixed with 1% paraformaldehyde, flash-frozen in cryoprotectant solution and
sectioned at a width of 30 microns using an ultramicrotome. Sections were stored in liquid
glycerol at 0oC before use. For staining with OPE1 and OPE2, sections were brought to room
temperature, washed twice for 15 minutes in PBS and immersed in a 5 uM aqueous solution of
dye for 1 hour, then washed twice more in buffer. Sections were laid on glass slides, covered with
hardset antifade medium and a coverslip mounted. Imaging was performed on a Leica SP8
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inverted laser scanning confocal microscope with 405nm laser diode illumination for OPE and
other dye lines as indicated in individual figures.

3. Discussion

Figure IV.1. Staining of rTg4510 tau-expressing mouse brain sections by OPE1 (top) and OPE2
(bottom). Green channels are autofluorescence from lipofuscin granules. Ring-shaped
neurofibrillary tangles are visible throughout the cortex. In the OPE2 images sections of
vasculature are also stained, for unknown reason.
After determination of the best-performing compounds from the selective screening
assay, they were evaluated for performance in ex vivo tissue staining, using a human tauexpressing transgenic model mouse.76 30 um thickness sagittal sections of whole
paraformaldehyde-fixed brains of rTg4510 neurofibrillary tangle-positive mice were immersed
for 30 minutes in a 5 um solution of dye and washed twice in PBS to remove excess dye. The
results, for OPE1 and OPE2, mirror the results of the in vitro assay and confirm the soundness of
the screening methodology. Even before optimization, the lead candidate OPE1 performs as well
as ThT in tissue staining, with low background, no undesired binding and bright emission. OPE2,
by contrast, found to be less selective in vitro, proves to have significant binding to an unknown
factor in the vasculature of both transgenic and wild-type mice. Results of these staining
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experiments deliver parallel results to those in the in vitro screening study: OPE1 proved selective
for the amyloid conformer, while OPE2 bound undesirably to some monomeric protein.
OPE1 staining was also effective in R1.40 APP/PSN1 transgenic mice expressing
amyloid plaques and in human brain tissue from patients with tau-associated frontotemporal
dementia. The effectiveness of OPE1 was also evaluated against paired helical filaments of tau
purified from human and mouse brain tissue, and against in vitro formed fibrils of ab40 and ab42.
Interestingly, spectral imaging of the neurofibrillary tangles and beta-amyloid plaques in brain
tissue reveals an emission spectrum of OPE1 that recapitulates that of the free dye, as opposed to
that of the dye bound to fibril suspensions in vitro. It is not especially surprising that the binding
mode of the dye would change in the crowded molecular environment of the cell.

Figure IV.2. Confocal fluorescence images of OPE1 staining amyloid deposits of different kinds,
and spectra from ROIs in those images and in vitro cuvette spectroscopy. Anticlockwise from
top: R1.40 cortical beta-amyloid plaques, a single neurofibrillary tangle in human frontotemporal
dementia sample, cortical neurofibrillary tangles from rTg4510 mouse brain.
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Figure IV.3. Differences in patterns of staining between OPE1 and ThT over the hippocampalcortical region. Chart reports frequency of tangles per nanoliter in confocal volumes from cortical
(Ctx) and hippocampal (Hip) regions stained by OPE1 or ThT.
We also compared the staining patterns of OPE1 and thioflavin T over the whole sagittal
sections of Tg4510 mouse brains, and found that while staining is identical at the level of
individual tangle morphology, the pattern over different anatomical regions is quite different.
Whereas thioflavin densely stains neuronal tau aggregates in the hippocampus, but labels only
sparsely in the cortex, OPE1 has the reverse pattern: dense staining in the cortex but sparse in the
hippocampus. The precise reason for this difference is unclear, but it presents an intriguing use
for OPE1 as a partner to ThT for revealing the complete picture of overall abnormal tau
aggregation across tissue.
Of the two dyes tested, OPE1 proved the more effective in terms of practical amyloid
imaging. OPE2 was found to bind extensively to an unidentified factor in the vasculature of the
amyloid-positive brains, possibly due to the presence of amyloid angiopathy. OPE1, by contrast,
bound quite selectively to tau tangles in the cortical and hippocampal regions of Tg4510 mouse
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brains, and to amyloid plaques in R1.40 brains, while displaying no binding in wild-type brains.
The structures bound by OPE1, and the non-vascular structures bound by OPE2, are similar in
morphology and distribution to those found by thioflavin T staining and immunofluorescence
with AT8 and AT180 antibodies, though complete colocalization was not demonstrated.

4. Conclusions
These experiments conclusively show the promise of OPEs as a scaffold for amyloidbinding dye development in a tissue environment. OPE1 stains both tau neurofibrillary tangles
and beta-amyloid plaques in mouse models, and neurofibrillary tangles in human brain tissue.
OPE2 stains the same structures but is hampered by non-selective binding to an additional factor
in the vasculature. Emission spectra of OPE1 in tissue are slightly different from those in solution
with similar protein aggregates. OPE1 stains similar structures to those stained by thioflavin T but
with a different distribution: OPE1 makes cortical tangles more visible, whereas thioflavin T
makes hippocampal tangles more visible. The effectiveness of OPE1 is a promising sign for
future development of similar compounds.

V. Triplet State Populations Triggered by
Solvation/Desolvation
1. Background
Desolvation and assembly into a patterned scaffold can affect more than just the
fluorescence of organic dyes. As mentioned in Section II, a useful property of poly(phenylene
ethynylene)s and polythiophenes is the good matching of their triplet energy levels with the
triplet-singlet transition of molecular oxygen, allowing these compounds to act as Type II
photosensitizers.77 In CH3OD solution, this process occurs with a quantum efficiency between
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0.15 and 0.4 for backbones without heteroatoms and up to 0.64 for thiophene derivatives.15,78 This
photochemical process is catalytic, neglecting photobleaching and self-oxidation, and in practice
is a very efficient means of destructively oxidizing cells and viruses to which the dyes will bind.
Previous efforts in antimicrobial chemotherapy have focused mainly on controlling migration of
the sensitizing dye through exploitation of selective binding as a means to selectively oxidize
only target organsisms, and this effect has provided good selectivity for bacterial vs. mammalian
cells and membranes.47,79 However, photosensitizer effects can also be controlled by tuning the
underlying photophysical processes. Photosensitization (type II) can only occur if the relevant
triplet state is populated sufficiently, and for sufficiently long, to allow an intermolecular
collision with free oxygen. The results of projects 1 and 2, as well as previous work by Hill and
others, have shown that binding/unbinding of ethyl ester-conjugated dyes can efficiently control
fluorescence by swift depopulation (in the solvated, quenched state) of the first excited singlet
state. Since the singlet excited state is upstream of all triplet states in the photochemical system
under investigation, and the intersystem crossing can be expected to be much slower than
radiative decay by fluorescence, the same desolvation-trigger paradigm used to control
fluorescence can also be used to control photosensitization and generation of reactive oxygen
species.80
The approach to this final project was to investigate the viability of controlling triplet
state populations by reversible self-assembly of a solvated OPE with surfactants. This possibility
was already discussed in an earlier paper by Tang and Ogawa,78 and could lead to useful
applications in controllable photooxidation of a wide range of targets.

2. Methods
Triplet transient absorption (TTA) spectroscopy was chosen as a proxy for singlet oxygen
sensitization. Direct observation of singlet oxygen by phosphorescence is limited to specific
solvents, and chemical detection introduces too many intervening factors into a delicate balance
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of self-assembly. TTA, by measuring directly the intensity and lifetime of triplet-triplet
transitions, can provide a great deal of information about the population of triplet states and the
rate of their generation and decay.
A solution of OPE1 (2 uM, 0.6 OD at 355nm) was prepared in Millipore water in a 10
mL cuvette with magnetic stirrer and gas-tight septum. The solution was sparged with argon by
syringe for 15 minutes before each experiment. TTA readings were performed on a home-built
instrument in the laboratory of Kirk Schanze at the University of Florida, using the second
harmonic of an Nd:YAG laser (355nm) as a pump source and a broadband flashlamp as a probe
source, with a grating monochromator and CCD camera. A stock solution of tetradecyl trimethyl
ammonium bromide was added incrementally between readings and the solution sparged again
with argon. Delay times were chosen to show the complete decay of the transient peak. Data was
analyzed in LabView and MATLAB.

3. Discussion & Conclusions

Figure V.1. TTA traces of S-OPE1-H and OPE1 in H2O solution, showing the complete lack of a
detectable triplet in the ethyl ester-terminated compound. Initial delay: 35 ns; delay increment:
500 ns. Curves shown are the average of 50 images each. Lifetime for S-OPE-1-H was derived by
fitting the peak decay curve to first-order kinetics.
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TTA traces of OPE1 and S-OPE-1(H) are shown in Figure V.1 above. S-OPE-1(H),
which is highly fluorescent in water, exhibits a significant transient absorption peak around 510
nm, decaying with a lifetime of ~4 microseconds. The OPE1, by contrast, has no detectable
transient absorption, indicating that either the triplet state is quenched completely before the 20 ns
initial instrumental delay, or the singlet state is quenched before it can cross over into the triplet
manifold. Having established the basic behavior of the dyes in water, an attempt was made to
determine if the transient peak in the quenched OPE1 could be restored by titration with an
oppositely charged surfactant, previously found to form strong complexes, shield the dye from
water-based quenching and photodamage, and significantly affect the dye’s behavior.50,56,58 The
TTA decay traces of OPE1 titrated with TTAB to a concentration just under CMC (1 mM for
TTAB) are shown in Figure V.1. With the addition of TTAB, a transient peak at 600 nm is seen
to appear with increasing intensity as more and more dye molecules are complexed and can reach
their triplet state.
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Figure V.2. Results of sub-micellar TTAB titration (0 to 49 uM) of 2 uM OPE1. (a): TTA traces,
35 ns initial delay, 3 us delay increment. (b): peak intensity at 583nm for each TTAB
concentration plotted against delay time. (c): peak intensity at 3035 ns delay plotted against
TTAB concentration, showing Langmuir-type binding saturation. (d): lifetime (from fitting of
decay curves in figure V.2(b) to first-order kinetics) plotted against TTAB concentration,
showing minor dependence of lifetime on TTAB concentration.
Just reaching the triplet state is not sufficient for the intended application, however. The
OPE has not been shown to switchably generate singlet oxygen, or switchably enact photodamage
to a living system of interest. The effects of random oxidation on particularly delicate systems are
also an unknown factor. However, the present study has provided a proof of concept which can
ground further investigation.
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VI. Conclusions
This thesis has reported the results of four different studies into the synthesis, properties
and behavior of oligo(p-phenylene ethynylene) electrolytes as tools for understanding and
perturbing biological systems. The detailed investigation of the influence of different cationic
groups on the effectiveness of photoactivated antimicrobials (Project 1) remains incomplete. A
library of 18 functional dyes was evaluated against model amyloid proteins and OPE1 and OPE2
were identified as useful solution-phase dyes for amyloid and lead candidates for further
evaluation (Project 2). The required properties for amyloid binding were determined to be steric
and Coulombic targeting by a detailed balance of factors, and a desolvation-triggered
fluorescence change mediated by solvent-interactive ethyl ester groups. OPE1 and OPE2 were
used to stain amyloid-positive brain tissue and OPE1 behaved equally well as thioflavin T, but
with some useful differences, while OPE2 exhibited unwanted binding elsewhere in the tissue
(Project 3). Finally, the use of surfactant-mediated self-assembly to control the accessibility and
population of triplet states in OPE organic dyes was investigated, and found to be a viable
approach worthy of additional study (Project 4).
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VII. Future Work
The future of research into these molecules is dependent on well-defined structureproperty relationships for rational molecular design. Projects 1, 2 and 3 all were based around
understanding the ways that molecular structure changes useful behavior in complex biological
systems, and each produced some useful information that could guide further efforts. As indicated
in Section III above, the solvent-sensitive emission property of the ester-conjugated OPEs was
discovered by accident, and has not been satisfactorily explained in theoretical terms. Future
workers could profit by understanding better how to control and improve the functionality of this
particular effect.
Synthesis of a new series of analogues to the existing OPE fluorophores will produce:
improved solvent-sensitive emitters, with either increased yield in the dequenched state or further
suppressed yield in the quenched state; and/or meaningful structure-function relationships for the
design of new hydrophobicity-sensing fluorescent dyes. “Turn-on” emission in response to
analyte is commonly-held goal in studies of fluorescent sensing. Previous studies have mostly
reported fluorogenesis resulting from forced planarization of an intramolecular rotor in the π
system81,82, while the emission changes of these OPEs are determined by the properties of the
solvent. Structure-function relationships for fluorogenesis do not exist satisfactorily. Improving
the fundamental understanding of fluorogens will have impact far beyond the specific sensing of
amyloid; solvent-based fluorogenesis can be used to make flexible sensor systems based on a
variety of self-assembly properties.
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